BridgeBio signs voluntary access and affordability agreement with US government
BBIO•Agreement expands access to Attruby
BridgeBio entered a voluntary agreement with the U.S. government to expand access to its marketed medicine, Attruby.
- The deal targets broader state Medicaid coverage via the GENEROUS Model, aiming to lower costs for patients.
- Attruby will remain available through Medicare Part D without future pricing mandates under the agreement.
- Terms were not disclosed; BridgeBio expects no future pricing mandates tied to the arrangement.
